I
n 2016, an estimated 5,660 people had been diagnosed with head and neck cancer (HNC) in Canada (Canadian Cancer Society, 2016) . Of these 1,335 tumors originated in the oropharynx and were consistently associated with human papillomavirus (HPV) infection (Canadian Cancer Society, 2016) . Although the incidence rates of HNCs have decreased, HPVassociated oropharyngeal squamous cell carcinomas have dramatically risen since the late 1990s (Canadian Cancer Society, 2016; Forte, Niu, Lockwood, & Bryant, 2012; Pytynia, Dahlstrom, & Sturgis, 2014) . This shift in HNC etiology has the potential to impose a substantial economic burden on health systems and has changed the population characteristics of survivors of HNC (Coughlan & Frick, 2012; Pytynia et al., 2014; Reich et al., 2016) .
The largest increase in HPV-associated HNC in Canada and the United States has been observed in men aged 40-59 years (Chaturvedi, Engels, Anderson, & Gillison, 2008; Forte et al., 2012) . Although HPVassociated HNCs tend to be diagnosed at more advanced stages, individuals with HPV-associated HNC are younger than those with non-HPV HNC, respond better to treatment, have a decreased risk of recurrence, and have better survival rates than individuals with non-HPV HNCs (Heath et al., 2012; Marur, D'Souza, Westra, & Forastiere, 2010; Pytynia et al., 2014) . Younger age at diagnosis leads to prolonged survivorship but also contributes to shorter productive work years, increased distress after treatment, and a diminished cancer-specific quality of life (QOL) (Johnson-Obaseki, McDonald, Corsten, & Rourke, 2012; Wells et al., 2015 Wells et al., , 2016 . Given the shifting demographic and clinical profile of those with HPV-associated HNC, this emerging population may experience a unique set of post-treatment needs when compared to survivors of non-HPV HNC (Powell & Evans, 2015) .
For instance, literature that has focused on all HNC cancers suggests that, if employed prior to diagnosis 
